Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation

Pediatric Blood and Cancer

Volumn 52, Issue 1, 2009, Pages 142-144

  Ohata, Yasuhisa ^a   Ohta, Hideaki ^a   Hashii, Yoshiko ^a   Tokimasa, Sadao ^a   Ozono, Keiichi ^a   Hara, Junichi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Chemotherapy; Children; Hematopoietic stem cell transplantation; Pneumocystis pneumonia; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; METHOTREXATE; PENTAMIDINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CHILD; DRUG EFFICACY; DRUG MEGADOSE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; METHODOLOGY; PNEUMOCYSTOSIS; PREMEDICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; PNEUMOCYSTIS INFECTIONS; PREMEDICATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 58149394113     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21774     Document Type: Article

References (20)

1. Harris RE, McCallister JA, Allen SA, et al. Prevention of pneumocystis pneumonia. Use of continuous sulfamethoxazole-trimethroprim therapy. Am J Dis Child 1980;134:35-38.
2. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977;297:1419-1426.
3. Krowka MJ, Rosenow EC III, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985;87:237-246.
4. Hughes WT, Feldman S, Chaudhary SC, et al. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 1978;92:285-291.
5. Wolff LJ. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics. Am J Pediatr Hematol Oncol 1984;6:267-276.
6. Thomas CF, Jr., Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498.
7. Behrman R, Fowler MG, Birnkrant D, et al. 1995 Revised Guidelines for Prophylaxis against Pneumocystis carinii Pneumonia for Children Infected with or Perinatally Exposed to Human Immunodeficiency Virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. MMWR Recomm Rep 1995;44:1-11.
8. Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987;316:1627-1632.
9. Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992;327:1842-1848.
10. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 1992;327:1836-1841.
11. Shankar SM, Nania JJ. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy. Paediatr Drugs 2007;9:301-309.
12. Prasad P, Nania JJ, Shankar SM. Pneumocystis pneumonia in children receiving chemotherapy. Pediatr Blood Cancer 2008;50:896-898.
13. Sepkowitz KA. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect 1992;7:114-121.
14. Munoz P, Munoz RM, Palomo J, et al. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine 1997;76:415-422.
15. Souza JP, Boeckh M, Gooley TA, et al. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis 1999;29:1467-1471.
16. Lindemulder S, Albano E. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients. Pediatrics 2007;120:e47-e51.
17. Kim SY, Dabb AA, Glenn DJ, et al. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatr Blood Cancer 2008;50:779-783.
18. Ekstrom B, Forsgren U, Ortengren B, et al. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I. Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim. Infection 1979;7:S359-S366.
19. Nolte H, Buttner H. Pharmacokinetics of trimethoprim and its combination with sulfamethoxazole in man after single and chronic oral administration. Chemotherapy 1973;18:274-284.
20. Pretet S, Salmon D, Rousseau F, et al. Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients. Am J Med 1993;94:35-40.